@davidvanduin.bsky.social
Infectious Diseases physician, transplant infectious diseases, antimicrobial resistance. University of North Carolina at Chapel Hill. EiC for JAC-AMR https://academic.oup.com/jacamr. #IDsky #TxID
How do microbiomes drive—and solve—AMR? 🧫
Join IMARI 26 pre-meeting workshop “Microbiomes as Reservoirs, Catalysts, and Solutions for AMR” with Dr. Amy Mathers & Dr. Romney Humphries to learn more.
Add it when you register ➡️ https://imari.org/registration/
🌍 For #WAAW2025, ISAC invited Member Societies to share efforts against #AMR
Dr Dena van den Bergh explains a study by South African Antibiotic Stewardship Programme that aims to empower the next generation of leaders to implement AMS at scale
Watch now: youtu.be/p2Jsaq3jhIE
@souhakanj.bsky.social
🎙️ Just published: Communicable E40: AMR in conflict and crisis zones
Hosted by Nav Narayanan & Thomas Tängdén
w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland)
Listen on #Communicable:
#IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social
📣 In a US cohort of >2500 #bacteremia patients, #Serratia marcescens was associated with persistent bacteremia and cardiac devices. Yet WGS showed genetic diversity of isolates: infections are not clonal.
#IDSky #clinmicro #MedSky @vancefowler.bsky.social
www.cmi-comms.org/article/S295...
Gave my 1st talk in NL: how to make multicenter data analysis with patient data actually work.
tl;dr: common data models (global interoperability) + LLMs (data harmonization, mapping, future-proofing) + federated learning (privacy)
Let me know what you think!
drive.google.com/file/d/1N3yk...
Looking forward to UNC Institute of Global Health and Infectious Diseases Friday talk globalhealth.unc.edu/education/fr...
31.10.2025 13:15 — 👍 3 🔁 1 💬 1 📌 0
🎯
24.10.2025 13:43 — 👍 2039 🔁 478 💬 77 📌 22
Peri–Covid-19 antibiotic use was associated with downstream antimicrobial resistance, and particularly the presence of gram-negative antibiotic-resistant organisms @nejm.org
evidence.nejm.org/doi/full/10....
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
Getting ready for #IDBugBowl @idweek.bsky.social Hope to see y’alll this afternoon. Come and cheer ur team UAB CCF ThomasJefferson and our international team Calcutta Troo Med #IDWeek2025 #IDSky
22.10.2025 13:36 — 👍 12 🔁 2 💬 1 📌 2
Dr Cesar Arias delivers Maxwell Finland Lecture #IDweek2025
“Antimicrobials save the patient and reduce infectiousness”
“My research comes from a question in one patient”
💯
Dr Yohei Doi now introducing Dr. Cesar Arias as the Maxwell Finland lecturer. #IDWeek2025
A pioneer in AMR research 🤩
As #IDWeek2025 begins, thousands of ID experts are uniting to defend science and public health. Urge Congress to fully fund ID research, preparedness and care, and hold the Administration accountable.
Your voice matters. Take action: https://idsociety.quorum.us/campaign/144678/
Dr Tamma: Susceptibility for cefuroxime, cefoodoxime, cefdinir, cefixime looking encouraging in ceftriaxone-susceptible Enterobacterales from BSI at Hopkins.
#IDweek2025 #IDsky
pubmed.ncbi.nlm.nih.gov/39745384/
Dr Tamma mentions the ongoing GOAT trial (PI Tamma & Cosgrove)
This will be a most needed and important study. clinicaltrials.gov/study/NCT060...
#IDweek2025 #IDsky
Dr Tamma now discusses the interpretation of ceftriaxone susceptibility testing for the use of oral cephalosporins.
#IDweek2025 #IDsky
Most people in observational studies of GN BSI were transitioned to oral late, and mostly to FQ or tmp/smx
Don’t miss @bwtrautner.bsky.social and I talk about what’s new in UTI (the UTI WikiGuideline and IDSA cUTI guideline) on Wednesday AM at 08:00 EST! #idweek2025 #idsky
17.10.2025 00:35 — 👍 7 🔁 2 💬 0 📌 0
Welcome to Atlanta #IDWeek2025! Check out this great guide to our city from the #EmoryID fellows! The Eastside Beltline is my fave
19.10.2025 16:25 — 👍 7 🔁 3 💬 1 📌 0
Dr Molina now discusses the important ARLG study DOTS.
Primary outcome was a desirability of outcome ranking analysis
Similar in dalba vs SOC
#idweek2025 #idsky
Curious about new antibacterials in the pipeline? Check out Monday 8am session in B302 and be (among) the first to know.
#IDweek2025 #IDsky
Dr. Molina now summarizing data on the use of long-acting anti-gram-positive bacterial agents: dalbavancin, and oritavancin
#IDweek2025 #IDsky
Nice summary by Dr. Nguyen on the use of oral B-lactams. Concerns over cefdinir bio availability. Overall limited but encouraging data for use in streptococcal infections. Probably too soon for MSSA.
#IDWeek2025 #IDsky
Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.
18.10.2025 17:13 — 👍 10 🔁 2 💬 3 📌 0
Don’t throw away your shot to watch the #IDWeek2025 Opening Plenary live! Tune in at 3:45PM ET to see Javier Muñoz and other special guests kick off the meeting: https://idweek2025.eventscribe.net/aaStatic.asp?SFP=WldXSkRZU0dAMjQyMjY
19.10.2025 16:00 — 👍 3 🔁 2 💬 0 📌 0
#IDWeek2025 let’s go!
#IDsky
This is an awesome opportunity @escmid.bsky.social @taescmid.bsky.social @idsainfo.bsky.social
09.10.2025 15:00 — 👍 1 🔁 1 💬 0 📌 0
The cover of the September 29, 2025, issue of The New Yorker.
An early look at next week’s cover: "Remote Control,” by Barry Blitt.
nyer.cm/6ApBXER
Ever since I learned about this study enrolling I have been eagerly awaiting the results. Researchers in Uganda took a centuries-old cultural practice mothers carrying babies on their backs in cloth wraps and turned it into a public health tool. You got to love it!
www.nejm.org/doi/full/10....
🎙️ Just published: Commun...
Hosted by @angelahuttner.bsky.social & @erinmccreary.bsky.social
w/ invited guests: Nick Daneman & Rob Fowler (Sunnybrook Health Sciences Centre)
Listen on @sidpharm.bsky.social: https://sidp.pinecast.co/
Listen on Communicable:
#IDSky #Clinmicro #MedSky
Infection with antimicrobial-resistant organisms significantly worsens outcomes in cancer patients
A survey of oncologists offers data that could support the development of oncology-specific AMS strategies and training programs:
doi.org/10.1093/jaca...
#IDSky #JACAMRNews
